Attached files
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): October 22, 2014
CANNAPHARMARX, INC.
---------------------
(Exact name of Registrant as specified in its charter)
Delaware 000-27055 24-4635140
---------------------------- ------------------------- ----------------------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation Identification No.)
One Collins Drive, Salem Business Center, Carneys Point, NJ 08069-3640
--------------------------------------------------
(Address of principal executive offices)
720-939-1133
-----------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
GOLDEN DRAGON HOLDING CO.
---------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
SECTION 5 - CORPORATE GOVERNANCE AND MANAGEMENT
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
Year
Articles of Amendment were filed with the Secretary of State of
Delaware on October 23, 2014 with an effective date of October 23, 2014. Copies
of the Articles of Amendment are attached as an exhibit. The Certificate only
changed the name of the Registrant to CannaPharmaRx, Inc.
Item 5.07 Submission of Matter to a Vote of Security Holders
Pursuant to a Definitive 14a Proxy Statement filed with the Securities
and Exchange Commission on October 9, 2014, the directors approved and the
shareholders voted to approve a name change from Golden Dragon Holding Co. to
CannaPharmaRx, Inc.
A Certificate of Amendment was filed with the Secretary of State of
Delaware on October 23, 2014 with an effective date of October 23, 2014.
On October 9, 2014, the Company notified FINRA of its intent to change
the Company's name to CannaPharmaRx, Inc. The Company is in the process of
providing information to FINRA. The name and symbol change will be effective for
trading upon FINRA approval.
SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS
Item 9.01 Financial Statements and Exhibits
The following is a complete list of exhibits filed as part of this
Report. Exhibit numbers correspond to the numbers in the exhibit table of Item
601 of Regulation S-K.
Exhibit # Description
3.1 Articles of Amendment filed October 23, 2014
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CANNAPHARMRARX, INC.
Formerly Golden Dragon Holding Co.
By: /s/ Gerry Crocker
----------------------------------
Chief Executive Officer
Date: October 23, 201
